Novo Holdings Edgewise Therapeutics, Inc. Transaction History
Novo Holdings
- $1.15 Billion
- Q2 2025
A detailed history of Novo Holdings transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Novo Holdings holds 5,350,000 shares of EWTX stock, worth $71.6 Million. This represents 6.11% of its overall portfolio holdings.
Number of Shares
5,350,000
Previous 5,350,000
-0.0%
Holding current value
$71.6 Million
Previous $118 Million
40.41%
% of portfolio
6.11%
Previous 10.59%
Shares
6 transactions
Others Institutions Holding EWTX
# of Institutions
191Shares Held
118MCall Options Held
54.3KPut Options Held
70.1K-
Orbimed Advisors LLC San Diego, CA15.5MShares$208 Million7.26% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.9MShares$133 Million2.84% of portfolio
-
Baker Bros. Advisors LP New York, NY7.31MShares$97.8 Million0.97% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.14MShares$82.2 Million3.76% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$80.6 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $846M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...